AIM
DCPH

Aigen Investment Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Aigen Investment Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-22,597
Closed -$364K – 1085
2023
Q4 		$364K Buy
22,597
+8,336
+58% +$106K 0.07% 432
2023
Q3 		$181K Buy
+14,261
New +$197K 0.03% 689
2022
Q4 		– Sell
-14,428
Closed -$267K – 825
2022
Q3 		$267K Buy
+14,428
New +$226K 0.04% 436

Other funds holding DCPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Aigen Investment Management's DCPH Position: Q1 2024 in Review

Aigen Investment Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2024, closing a stake of 22,597 shares — an estimated $364K sold.

Aigen Investment Management first reported a position in DCPH in Q3 2022 and held it in 3 quarters. The position peaked at $364K in Q4 2023. 177 funds tracked by Wall St. Rank hold DCPH as of Q1 2024.

  • Aigen Investment Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Aigen Investment Management sold 22,597 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $364K.
  • Aigen Investment Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2022 and held it in 3 quarters.
  • Aigen Investment Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $364K in Q4 2023.
  • 177 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Aigen Investment Management's 13F filing for Q1 2024, filed 14 May 2024.